Detalles de la búsqueda
1.
Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study.
Neuropsychopharmacology
; 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649428
2.
Concordance of Alzheimer's Disease-Related Biomarkers Between Intraventricular and Lumbar Cerebrospinal Fluid in Idiopathic Normal Pressure Hydrocephalus.
J Alzheimers Dis
; 91(1): 305-319, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36404546
3.
Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder.
Transl Psychiatry
; 13(1): 266, 2023 07 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37482560
4.
The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study.
Neuropsychopharmacology
; 46(5): 1004-1010, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33070154
5.
Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
J Alzheimers Dis
; 80(4): 1629-1642, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33720890
6.
Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder.
Transl Psychiatry
; 9(1): 240, 2019 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31578318
7.
The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder.
Transl Psychiatry
; 9(1): 216, 2019 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31481683
8.
The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia.
J Psychopharmacol
; 33(2): 202-209, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30644312
9.
Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects.
J Psychopharmacol
; 32(12): 1330-1340, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30182786
10.
Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study.
Psychopharmacology (Berl)
; 235(4): 1107-1119, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29392371
11.
Fatty Acid Amide Hydrolase Inhibition by JNJ-42165279: A Multiple-Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers.
Clin Transl Sci
; 11(4): 397-404, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29575526
12.
A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity.
J Psychopharmacol
; 32(6): 668-677, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29848147
13.
S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-ß Plaques and Tau in Brain Biopsies.
J Alzheimers Dis
; 64(1): 171-179, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29865068
14.
Dose-dependent effects of the CRF(1) receptor antagonist R317573 on regional brain activity in healthy male subjects.
Psychopharmacology (Berl)
; 208(1): 109-19, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19911168
15.
Patients with and without rheumatoid arthritis benefit equally from preoperative epoetin-alpha treatment.
Acta Orthop
; 77(4): 677-83, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16929448
Resultados
1 -
15
de 15
1
Próxima >
>>